• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短药物-光间隔脂质体化学光疗的药代动力学和药效学。

Pharmacokinetics and pharmacodynamics of liposomal chemophototherapy with short drug-light intervals.

机构信息

Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA.

Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14214, USA.

出版信息

J Control Release. 2019 Mar 10;297:39-47. doi: 10.1016/j.jconrel.2019.01.030. Epub 2019 Jan 23.

DOI:10.1016/j.jconrel.2019.01.030
PMID:30684512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6399029/
Abstract

Chemophototherapy (CPT) merges photodynamic therapy with chemotherapy and can substantially enhance drug delivery. Using a singular liposomal formulation for CPT, we describe a semi-mechanistic pharmacokinetic-pharmacodynamic (PK/PD) model to investigate observed antitumor effects. Long-circulating, sterically-stabilized liposomes loaded with doxorubicin (Dox) stably incorporate small amounts of a porphyrin-phospholipid (PoP) photosensitizer in the bilayer. These were administered intravenously to mice bearing low-passage, patient-derived pancreatic cancer xenografts (PDX). Dox PK was described with a two-compartment model and tumor drug disposition kinetics were modeled with first-order influx and efflux rates. Tumor irradiation with 665 nm laser light (200 J/cm) 1 h after liposome administration increased tumor vascular permeabilization and drug accumulation, which was accounted for in the PK/PD model with increased tumor influx and efflux rates by approximately 12- and 4- fold, respectively. This modeling approach provided an overall 7-fold increase in Dox area under the curve in the tumor, matching experimental data (7.4-fold). A signal transduction model based on nonlinear direct cell killing accounted for observed tumor growth patterns. This PK/PD model adequately describes the CPT anti-PDX tumor response based on enhanced drug delivery at the short drug-light interval used.

摘要

化学光疗(CPT)将光动力疗法与化学疗法相结合,可以显著增强药物递送。我们使用单一的脂质体制剂进行 CPT,描述了一个半机械的药代动力学-药效学(PK/PD)模型,以研究观察到的抗肿瘤效果。载有阿霉素(Dox)的长循环、空间稳定的脂质体在双层中稳定地掺入少量卟啉磷脂(PoP)光敏剂。这些脂质体被静脉注射到携带低传代、患者来源的胰腺癌异种移植(PDX)的小鼠体内。用两室模型描述 Dox 的 PK,并用一阶流入和流出率来模拟肿瘤药物处置动力学。在脂质体给药后 1 小时用 665nm 激光(200J/cm)照射肿瘤,增加了肿瘤血管通透性和药物积累,这在 PK/PD 模型中通过增加肿瘤流入和流出率来解释,分别增加了约 12 倍和 4 倍。这种建模方法使肿瘤中 Dox 的曲线下面积总体增加了 7 倍,与实验数据(7.4 倍)相匹配。基于非线性直接细胞杀伤的信号转导模型解释了观察到的肿瘤生长模式。该 PK/PD 模型充分描述了基于短药物-光间隔增强药物递送的 CPT 抗 PDX 肿瘤反应。

相似文献

1
Pharmacokinetics and pharmacodynamics of liposomal chemophototherapy with short drug-light intervals.短药物-光间隔脂质体化学光疗的药代动力学和药效学。
J Control Release. 2019 Mar 10;297:39-47. doi: 10.1016/j.jconrel.2019.01.030. Epub 2019 Jan 23.
2
Short Drug-Light Intervals Improve Liposomal Chemophototherapy in Mice Bearing MIA PaCa-2 Xenografts.短药物-光照间隔可改善携带 MIA PaCa-2 异种移植物的小鼠的脂质体化学光疗。
Mol Pharm. 2018 Sep 4;15(9):3682-3689. doi: 10.1021/acs.molpharmaceut.8b00052. Epub 2018 Apr 2.
3
PK/PD model for liposomal chemophototherapy.脂质体化学光动力疗法的药代动力学/药效学模型
J Control Release. 2019 Mar 10;297:102. doi: 10.1016/j.jconrel.2019.02.022.
4
Vessel-Targeted Chemophototherapy with Cationic Porphyrin-Phospholipid Liposomes.载药脂质体靶向光动力学治疗。
Mol Cancer Ther. 2017 Nov;16(11):2452-2461. doi: 10.1158/1535-7163.MCT-17-0276. Epub 2017 Jul 20.
5
Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release.包封于隐形脂质体中的阿霉素具有光触发药物释放功能。
Biomaterials. 2016 Jan;75:193-202. doi: 10.1016/j.biomaterials.2015.10.027. Epub 2015 Oct 23.
6
Blood Interactions, Pharmacokinetics, and Depth-Dependent Ablation of Rat Mammary Tumors with Photoactivatable, Liposomal Doxorubicin.光活化脂质体阿霉素对大鼠乳腺肿瘤的血液相互作用、药代动力学和深度依赖性消融。
Mol Cancer Ther. 2019 Mar;18(3):592-601. doi: 10.1158/1535-7163.MCT-18-0549. Epub 2018 Dec 26.
7
Metal Chelation Modulates Phototherapeutic Properties of Mitoxantrone-Loaded Porphyrin-Phospholipid Liposomes.金属螯合调节载米托蒽醌的卟啉-磷脂脂质体的光疗特性。
Mol Pharm. 2016 Feb 1;13(2):420-7. doi: 10.1021/acs.molpharmaceut.5b00653. Epub 2015 Dec 31.
8
Intrabilayer Cu Labeling of Photoactivatable, Doxorubicin-Loaded Stealth Liposomes.光活化、阿霉素负载隐形脂质体的层间 Cu 标记。
ACS Nano. 2017 Dec 26;11(12):12482-12491. doi: 10.1021/acsnano.7b06578. Epub 2017 Dec 5.
9
Rapid Light-Triggered Drug Release in Liposomes Containing Small Amounts of Unsaturated and Porphyrin-Phospholipids.含少量不饱和及卟啉磷脂的脂质体中光触发的快速药物释放
Small. 2016 Jun;12(22):3039-47. doi: 10.1002/smll.201503966. Epub 2016 Apr 28.
10
Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.硒功能化脂质体用于系统递送阿霉素,具有增强的药代动力学和抗癌效果。
Eur J Pharm Biopharm. 2018 Jan;122:87-95. doi: 10.1016/j.ejpb.2017.10.010. Epub 2017 Oct 13.

引用本文的文献

1
Saliva-derived components can enhance the performance of toluidine blue in photodynamic therapy.唾液衍生成分可提高甲苯胺蓝在光动力疗法中的性能。
Front Pharmacol. 2025 Feb 13;16:1538520. doi: 10.3389/fphar.2025.1538520. eCollection 2025.
2
Fluence Rate-Dependent Kinetics of Light-Triggered Liposomal Doxorubicin Assessed by Quantitative Fluorescence-Based Endoscopic Probe.基于定量荧光的内镜探针评估光触发脂质体阿霉素的光通量率依赖性动力学
Int J Mol Sci. 2025 Jan 30;26(3):1212. doi: 10.3390/ijms26031212.
3
Engineering photodynamics for treatment, priming and imaging.用于治疗、启动和成像的工程光动力学。
Nat Rev Bioeng. 2024 Sep;2(9):752-769. doi: 10.1038/s44222-024-00196-z. Epub 2024 Jun 19.
4
Fluence rate-dependent kinetics of light-triggered liposomal doxorubicin assessed by quantitative fluorescence-based endoscopic probe.基于定量荧光的内镜探针评估光触发脂质体阿霉素的光通量率依赖性动力学。
Res Sq. 2025 Jan 3:rs.3.rs-5727534. doi: 10.21203/rs.3.rs-5727534/v1.
5
Fluence rate-dependent kinetics of light-triggered liposomal doxorubicin assessed by quantitative fluorescence-based endoscopic probe.基于定量荧光的内镜探针评估光触发脂质体阿霉素的光通量率依赖性动力学
bioRxiv. 2024 Dec 29:2024.12.29.630668. doi: 10.1101/2024.12.29.630668.
6
Nanobubble Contrast Enhanced Ultrasound Imaging: A Review.纳米气泡超声对比增强成像:综述
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Nov-Dec;16(6):e2007. doi: 10.1002/wnan.2007.
7
Engineering Radiocatalytic Nanoliposomes with Hydrophobic Gold Nanoclusters for Radiotherapy Enhancement.工程化具有疏水性金纳米团簇的放射催化纳米脂质体以增强放射治疗效果
Adv Mater. 2024 Dec;36(50):e2404605. doi: 10.1002/adma.202404605. Epub 2024 Oct 30.
8
A review of FDA approved drugs and their formulations for the treatment of breast cancer.对美国食品药品监督管理局(FDA)批准的用于治疗乳腺癌的药物及其制剂的综述。
Front Pharmacol. 2023 Jul 28;14:1184472. doi: 10.3389/fphar.2023.1184472. eCollection 2023.
9
Patient-derived xenograft models in cancer therapy: technologies and applications.癌症治疗中的患者来源异种移植模型:技术与应用。
Signal Transduct Target Ther. 2023 Apr 12;8(1):160. doi: 10.1038/s41392-023-01419-2.
10
2D Nano-Sonosensitizers Facilitate Energy Transfer to Enhance Sonodynamic Therapy.二维纳米声敏剂促进能量转移以增强声动力学治疗。
Adv Mater. 2023 May;35(19):e2212069. doi: 10.1002/adma.202212069. Epub 2023 Mar 26.

本文引用的文献

1
Short Drug-Light Intervals Improve Liposomal Chemophototherapy in Mice Bearing MIA PaCa-2 Xenografts.短药物-光照间隔可改善携带 MIA PaCa-2 异种移植物的小鼠的脂质体化学光疗。
Mol Pharm. 2018 Sep 4;15(9):3682-3689. doi: 10.1021/acs.molpharmaceut.8b00052. Epub 2018 Apr 2.
2
Multifunctional Liposomes for Image-Guided Intratumoral Chemo-Phototherapy.多功能脂质体用于图像引导的肿瘤内化疗-光疗。
Adv Healthc Mater. 2017 Aug;6(16). doi: 10.1002/adhm.201700253. Epub 2017 May 15.
3
Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapy.脂质体伊立替康治疗吉西他滨难治性转移性胰腺癌:疗效、安全性及在治疗中的地位
Ther Adv Med Oncol. 2017 Mar;9(3):159-170. doi: 10.1177/1758834016688816. Epub 2017 Mar 1.
4
Interstitial Photodynamic Therapy-A Focused Review.间质光动力疗法——聚焦综述
Cancers (Basel). 2017 Jan 24;9(2):12. doi: 10.3390/cancers9020012.
5
Chemophototherapy: An Emerging Treatment Option for Solid Tumors.化学光动力疗法:实体肿瘤的一种新兴治疗选择。
Adv Sci (Weinh). 2016 May 24;4(1):1600106. doi: 10.1002/advs.201600106. eCollection 2017 Jan.
6
Sphingomyelin Liposomes Containing Porphyrin-phospholipid for Irinotecan Chemophototherapy.含卟啉磷脂的鞘磷脂脂质体用于伊立替康化学光动力疗法
Theranostics. 2016 Oct 1;6(13):2329-2336. doi: 10.7150/thno.15701. eCollection 2016.
7
Rapid Light-Triggered Drug Release in Liposomes Containing Small Amounts of Unsaturated and Porphyrin-Phospholipids.含少量不饱和及卟啉磷脂的脂质体中光触发的快速药物释放
Small. 2016 Jun;12(22):3039-47. doi: 10.1002/smll.201503966. Epub 2016 Apr 28.
8
Intracellular PK/PD Relationships of Free and Liposomal Doxorubicin: Quantitative Analyses and PK/PD Modeling.游离和脂质体阿霉素的细胞内药代动力学/药效学关系:定量分析与药代动力学/药效学建模
Mol Pharm. 2016 Apr 4;13(4):1358-65. doi: 10.1021/acs.molpharmaceut.6b00008. Epub 2016 Mar 16.
9
Metal Chelation Modulates Phototherapeutic Properties of Mitoxantrone-Loaded Porphyrin-Phospholipid Liposomes.金属螯合调节载米托蒽醌的卟啉-磷脂脂质体的光疗特性。
Mol Pharm. 2016 Feb 1;13(2):420-7. doi: 10.1021/acs.molpharmaceut.5b00653. Epub 2015 Dec 31.
10
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.奈拉滨脂质体、氟尿嘧啶和亚叶酸联合治疗既往基于吉西他滨方案治疗后的转移性胰腺导管腺癌(NAPOLI-1):一项全球性、随机、开放标签、3 期临床试验。
Lancet. 2016 Feb 6;387(10018):545-557. doi: 10.1016/S0140-6736(15)00986-1. Epub 2015 Nov 29.